Instruments, Medical & Lab Equipment

Cytek Biosciences, Inc. CEO pay

Wenbin Jiang, Ph.D. Chief Executive Officer and President. Fiscal year 2025, as reported to the SEC.

Total compensation

$5.1M

$5,120,061 for fiscal 2025: the Summary Compensation Table total, with stock and option awards at their grant-date value.

Definitive proxy statement, filed 2026-04-28SEC accession number 0001140361-26-017479

In context

The median chief executive among 36 Instruments, Medical & Lab Equipment companies with $100M – $500M in revenue was paid $2.9M. The middle half ranged from $1.7M to $4.9M.

Wenbin Jiang's total is above that median.

See how your pay compares to Cytek Biosciences, Inc.'s peers

CEOSalary breaks this total into salary, bonus, stock and option awards, builds a peer set of comparable companies around it, and places your own package against them, with every figure cited to its filing.

Start a 3-day trial

Source: Cytek Biosciences, Inc.'s definitive proxy statement (SEC Form DEF 14A), Summary Compensation Table, fiscal year 2025. Figures are as reported by the company and are not adjusted or estimated. Context figures are from CEOSalary's snapshot of SEC filings as of 2026-10-28. Not financial, legal or compensation-consulting advice.